Pyxis Oncology, Inc. (PYXS)

1.665 +0.12 (+8.12%) USD  |  NASDAQ  |  Mar 16, 16:00
1.665 0.00 (0.00%) After-Hours: 20:00
More

Pyxis Oncology EPS Diluted (Quarterly) : -0.3517 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for PYXS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. 1.191
Nephros, Inc. 0.0055
Spero Therapeutics, Inc. -0.1312
Processa Pharmaceuticals, Inc. -1.808
Alpha Teknova, Inc. -0.0889

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -22.00M
Total Expenses (Quarterly) 22.00M
Enterprise Value 37.23M
Earnings Yield -95.60%
Normalized Earnings Yield -80.80